Wnt-1 signal as a potential cancer therapeutic target

Drug News and Perspectives

Volumn 19, Issue 1, 2006, Pages 27-31

  You, Liang ^a   Kim, Jae ^a   He, Biao ^a   Xu, Zhidong ^a   McCormick, Frank ^a   Jablons, David M ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Cancer Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FRIZZLED PROTEIN; MONOCLONAL ANTIBODY; PROTEIN INHIBITOR; PROTEIN WNT INHIBITORY FACTOR; UNCLASSIFIED DRUG; WNT1 PROTEIN;

APOPTOSIS; BREAST TUMOR; CANCER; CARCINOGENESIS; DRUG BINDING; DRUG EFFECT; GENE MAPPING; GENE MUTATION; HEPATITIS C; HUMAN; NEURAL TUBE; NONHUMAN; PROSTATE CANCER; PROTEIN BINDING; PROTEIN EXPRESSION; PROTO ONCOGENE; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ANTIBODIES, BLOCKING; APOPTOSIS; HUMANS; NEOPLASMS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; WNT1 PROTEIN;

EID: 33645411180     PISSN: 02140934     EISSN: None     Source Type: Journal    
DOI: 10.1358/dnp.2006.19.1.965871     Document Type: Review

References (44)

1. Nusse, R. and Varmus, H.E. Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell 1982, 31: 99-109.
2. Cadigan, K.M. and Nusse, R. Wnt signaling: a common theme in animal development. Genes Dev 1997, 11: 3286-305.
3. Reya, T., Duncan, A.W., Ailles, L. et al. A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature 2003, 423: 409-14.
4. Wodarz, A. and Nusse, R. Mechanisms of Wnt signaling in development. Annu Rev Cell Dev Biol 1998, 14: 59-88.
5. Moon, R.T., Kohn, A.D., De Ferrari, G.V. and Kaykas, A. WNT and beta-catenin signalling: diseases and therapies. Nat Rev Genet 2004, 5: 691-701.
6. You, L., He, B., Uematsu, K. et al. Inhibition of Wnt-1 signaling induces apoptosis in beta-catenin-deficient mesothelioma cells. Cancer Res 2004, 64: 3474-8.
7. He, T.C., Sparks, A.B., Rago, C. et al. Identification of c-MYC as a target of the APC pathway. Science 1998, 281: 1509-12.
8. Veeman, M.T., Axelrod, J.D., and Moon, R.T. A second canon. Functions and mechanisms of beta-catenin-independent Wnt signaling. Dev Cell 2003, 5: 367-77.
9. Nusse, R., Brown, A., Papkoff, J. et al. A new nomenclature for int-1 and related genes: the Wnt gene family. Cell 1991, 64: 231.
10. Rijsewijk, F., Schuermann, M., Wagenaar, E., Parren, P., Weigel, D., and Nusse, R. The Drosophila homolog of the mouse mammary oncogene int-1 is identical to the segment polarity gene wingless. Cell 1987, 50: 649-57.
11. van Ooyen, A. and Nusse, R. Structure and nucleotide sequence of the putative mammary oncogene int-1; proviral insertions leave the protein-encoding domain intact. Cell 1984, 39: 233-40.
12. van Ooyen, A., Kwee, V., and Nusse, R. The nucleotide sequence of the human int-1 mammary oncogene: evolutionary conservation of coding and non-coding sequences. EMBO J 1985, 4: 2905-9.
13. Fung, Y.K., Shackleford, G.M., Brown. A.M., Sanders, G.S., and Varmus, H.E. Nucleotide sequence and expression in vitro of cDNA derived from mRNA of int-1, a provirally activated mouse mammary oncogene. Mol Cell Biol 1985, 5: 3337-44.
14. Brown, A.M., Papkoff, J., Fung, Y.K., Shackleford, G.M., and Varmus, H.E. Identification of protein products encoded by the proto-oncogene int-1. Mol Cell Biol 1987, 7: 3971-7.
15. Zhai, L., Chaturvedi, D., and Cumberledge, S. Drosophila wnt-1 undergoes a hydrophobic modification and is targeted to lipid rafts, a process that requires porcupine. J Biol Chem 2004, 279: 33220-7.
16. Parkin, N.T., Kitajewski, J., and Varmus, H.E. Activity of Wnt-1 as a transmembrane protein. Genes Dev 1993, 7: 2181-93.
17. Jue, S.F., Bradley, R.S., Rudnicki, J.A., Varmus, H.E., and Brown, A.M. The mouse Wnt-1 gene can act via a paracrine mechanism in transformation of mammary epithelial cells. Mol Cell Biol 1992, 12: 321-8.
18. McMahon, A.P. and Bradley, A. The Wnt-1 (int-1) proto-oncogene is required for development of a large region of the mouse brain. Cell 1990, 62: 1073-85.
19. Thomas, K.R. and Capecchi, M.R. Targeted disruption of the murine int-1 proto-oncogene resulting in severe abnormalities in midbrain and cerebellar development. Nature 1990, 346: 847-50.
20. Gavin, B.J., McMahon, J.A., and McMahon, A.P. Expression of multiple novel Wnt-1/int-1-related genes during fetal and adult mouse development. Genes Dev, 4: 2319-2332, 1990.
21. Shackleford, G.M. and Varmus, H.E. Expression of the proto-oncogene int-1 is restricted to postmeiotic male germ cells and the neural tube of mid-gestational embryos. Cell, 50: 89-95, 1987.
22. Brown, A.M., Wildin, R.S., Prendergast, T.J., and Varmus, H.E. A retrovirus vector expressing the putative mammary oncogene int-1 causes partial transformation of a mammary epithelial cell line. Cell 1986, 46: 1001-9.
23. Shimizu, H., Julius, M.A., Giarre, M., Zheng, Z., Brown, A.M., and Kitajewski, J. Transformation by Wnt family proteins correlates with regulation of beta-catenin. Cell Growth Differ 1997, 8: 1349-58.
24. Gunther, E.J., Moody, S.E., Belka, G.K. et al. Impact of p53 loss on reversal and recurrence of conditional Wnt-induced tumorigenesis. Genes Dev 2003, 17: 488-501.
25. He, B., Reguart, N., You, L. et al. Blockade of Wnt-1 signaling induces apoptosis in human colorectal cancer cells containing downstream mutations. Oncogene 2005, 24: 3054-8.
26. Simon, M., Grandage, V.L., Linen, D.C., and Khwaja, A. Constitutive activation of the Wnt/beta-catenin signalling pathway in acute myeloid leukaemia. Oncogene 2005, 24: 2410-20.
27. Mizushima, T., Nakagawa, H., Kamberov, Y.G., Wilder, E.L., Klein, P.S., and Rustgi, A.K. Wnt-1 but not epidermal growth factor induces beta-catenin/T-cell factor-dependent transcription in esophageal cancer cells. Cancer Res 2002, 62: 277-82.
28. Zhang, W.M., Lo Muzio, L., Rubini, C., and Van, G. Effect of WNT-1 on beta-catenin expression and its relation to Ki-67 and tumor differentiation in oral squamous cell carcinoma. Oncol Rep 2005, 13: 1095-9.
29. Chen, G. Shukeir, N., Potti, A., Sircar, K., Aprikian, A., Goltzman, D., and Rabbani, S.A. Up-regulation of Wnt-1 and beta-catenin production in patients with advanced metastatic prostate carcinoma: potential pathogenetic and prognostic implications. Cancer 2004, 101: 1345-56.
30. Cha, M.Y., Kim, C.M., Park, Y.M., and Ryu, W. S. Hepatitis B virus X protein is essential for the activation of Wnt/beta-catenin signaling in hepatoma cells. Hepatology 2004, 39: 1683-93.
31. Fukutomi, T., Zhou, Y., Kawai, S., Eguchi, H., Wands, J.R., and Li, J. Hepatitis C virus core protein stimulates hepatocyte growth: correlation with upregulation of wnt-1 expression. Hepatology 2005, 41: 1096-105.
32. Rhee, C.S., Sen, M., Lu, D. et al. Wnt and frizzled receptors as potential targets for immunotherapy in head and neck squamous cell carcinomas. Oncogene 2002, 21: 6598-605.
33. He, B., You, L., Uematsu, K. et al. A monoclonal antibody against Wnt-1 induces apoptosis in human cancer cells. Neoplasia 2004, 6: 7-14.
34. Mikami, I., You, L., He, B. et al. Efficacy of Wnt-1 monoclonal antibody in sarcoma cells. BMC Cancer 2005, 5: 53.
35. Suzuki, H., Watkins, D.N., Jair, K.W. et al. Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet 2004, 36: 417-22.
36. Bafico, A., Liu, G., Goldin, L., Harris, V., and Aaronson, S.A. An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells. Cancer Cell 2004, 6: 497-506.
37. Kim, C.F., Jackson, E.L., Woolfenden, A.E. et al. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 2005, 121: 823-35.
38. Uematsu, K., Kanazawa, S., You, L. et al. Wnt pathway activation in mesothelioma: evidence of Dishevelled overexpression and transcriptional activity of beta-catenin. Cancer Res 2003, 63: 4547-51.
39. Uematsu, K., He, B., You, L., Xu, Z., McCormick, F., and Jablons, D.M. Activation of the Wnt pathway in non small cell lung cancer: evidence of dishevelled overexpression. Oncogene 2003, 22: 7218-21.
40. Porfiri, E., Rubinfeld, B., Albert, I., Hovanes, K., Waterman, M., and Polakis, P. Induction of a beta-catenin-LEF-1 complex by wnt-1 and transforming mutants of beta-catenin. Oncogene 1997, 15: 2833-9.
41. You, Z., Saims, D., Chen, S. et al. Wnt signaling promotes oncogenic transformation by inhibiting c-Myc-induced apoptosis. J Cell Biol 2002, 157: 429-40.
42. Tetsu, O. and McCormick, F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999, 398: 422-6.
43. Shou, J., Ali-Osman, F., Multani, A.S., Pathak, S., Fedi, P., and Srivenugopal, K.S. Human Dkk-1, a gene encoding a Wnt antagonist, responds to DNA damage and its overexpression sensitizes brain tumor cells to apoptosis following alkylation damage of DNA. Oncogene 2002, 21: 878-89.
44. Lee, A.Y., He, B., You, L. et al. Dickkopf-1 antagonizes Wnt signaling independent of beta-catenin in human mesothelioma. Biochem Biophys Res Commun 2004, 323: 1246-50.